Kimura Tetsushi, Takagi Hitoshi, Kita Mihori, Watanabe Daisuke, Yoshimura Nagahisa
From the Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Retin Cases Brief Rep. 2009 Spring;3(2):167-9. doi: 10.1097/ICB.0b013e31816bbed4.
To investigate the efficacy of intravitreal injection of triamcinolone acetonide (TA) for treatment of cystoid foveal edema (CFE) associated with Coats' disease.
A 32-year-old man with a 28-month history of Coats' disease received an intravitreal TA injection (4 mg) in the right eye.
Visual acuity improved from 20/200 to 20/50, and foveal thickness decreased from 701 μm to 216 μm 45 days after treatment.
Intravitreal TA injection might temporarily improve visual acuity in eyes with CFE associated with Coats' disease.
探讨玻璃体内注射曲安奈德（TA）治疗与科茨病相关的黄斑囊样水肿（CFE）的疗效。
一名患有28个月科茨病病史的32岁男性右眼接受了玻璃体内TA注射（4毫克）。
治疗45天后，视力从20/200提高到20/50，黄斑中心凹厚度从701微米降至216微米。
玻璃体内注射TA可能会暂时改善与科茨病相关的CFE患者的视力。
